Australia Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Nicotine Replacement Therapy, E-Cigarettes), By Distribution Channel (Online, Offline), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology and Scope

• 1.1. Market Segmentation
• 1.2. Market Definitions
• 1.3. Objectives
  • 1.3.1 Objective - 1
  • 1.3.2 Objective - 2
  • 1.3.3 Objective - 3
• 1.4. Research Methodology
  • 1.4.1 Information Procurement
  • 1.4.2 Purchased Database
  • 1.4.3 GVR's Internal Database
  • 1.4.4 Secondary Sources
  • 1.4.5. Primary Research
• 1.5 Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
• 1.8 Commodity Flow Analysis
  • 1.8.1 List Of Secondary Sources
  • 1.8.2 List Of Abbreviations
  • 1.8.3 List Of Primary Sources

Chapter 2 Executive Summary

• 2.1 Market And Product Segment Snapshot
• 2.2 Distribution Channel Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Australia Nicotine Replacement Therapy Market Variables, Trends, And Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Technological Advancements
    • 3.2.1.2 Rise In Awareness About Ill Effects Of Smoking
    • 3.2.1.3 Rising Number Of People Undergoing Smoking Cessation
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Stringent Regulatory Framework
• 3.3 Regulatory Scenario
• 3.4 Epidemiology Analysis
• 3.5 Business Environment Analysis
  • 3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.5.2 Industry Analysis - Porter's

Chapter 4 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Australia Nicotine Replacement Therapy Market: Product Movement Analysis
• 4.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Product (USD Million)
  • 4.2.1 Nicotine Replacement Therapy
    • 4.2.1.1 Inhalers
    • 4.2.1.2 Gum
    • 4.2.1.3 Transdermal Patches
    • 4.2.1.4 Sublingual Tablets
    • 4.2.1.5 Lozenges
    • 4.2.1.6 Others
  • 4.2.2 E-cigarettes
  • 4.2.3 Heat-not-burn Tobacco Products

Chapter 5 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

• 5.1 Australia Nicotine Replacement Therapy Market: Distribution Channel Movement Analysis
• 5.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Distribution Channel (USD Million)
  • 5.2.1 Online
  • 5.2.2 Offline
    • 5.2.2.1 Hospital Pharmacies
    • 5.2.2.2 Retail Pharmacies
    • 5.2.2.3 Others (Supermarkets & Other Modes)

Chapter 6 Australia Nicotine Replacement Therapy Market - Competitive Landscape

• 6.1 Participant's Overview
• 6.2 Financial Performance
• 6.3 Participant Categorization
  • 6.3.1 Market Leaders
  • 6.3.2 Market Share Analysis, 2023
  • 6.3.3 Company Profiles
    • 6.3.3.1 Philip Morris Products S.A. (Altria Group)
    • 6.3.3.1.1 Company Overview
    • 6.3.3.1.2 Financial Performance
    • 6.3.3.1.3 Product Benchmarking
    • 6.3.3.1.4 Strategic Initiatives
    • 6.3.3.2 British American Tobacco P.L.C.
    • 6.3.3.2.1 Company Overview
    • 6.3.3.2.2 Financial Performance
    • 6.3.3.2.3 Product Benchmarking
    • 6.3.3.2.4 Strategic Initiatives
    • 6.3.3.3 Haleon Group Of Companies
    • 6.3.3.3.1 Company Overview
    • 6.3.3.3.2 Financial Performance
    • 6.3.3.3.3 Product Benchmarking
    • 6.3.3.3.4 Strategic Initiatives
    • 6.3.3.4 Johnson & Johnson Services, Inc.
    • 6.3.3.4.1 Company Overview
    • 6.3.3.4.2 Financial Performance
    • 6.3.3.4.3 Product Benchmarking
    • 6.3.3.4.4 Strategic Initiatives
    • 6.3.3.5 Liber Pharmaceuticals Pty Ltd
    • 6.3.3.5.1 Company Overview
    • 6.3.3.5.2 Financial Performance
    • 6.3.3.5.3 Product Benchmarking
    • 6.3.3.5.4 Strategic Initiatives
    • 6.3.3.6 Philip Morris Products S.A. (Altria Group)
    • 6.3.3.6.1 Company Overview
    • 6.3.3.6.2 Financial Performance
    • 6.3.3.6.3 Product Benchmarking
    • 6.3.3.6.4 Strategic Initiatives
    • 6.3.3.7 Alphapharm Pty Limited
    • 6.3.3.7.1 Company Overview
    • 6.3.3.7.2 Financial Performance
    • 6.3.3.7.3 Product Benchmarking
    • 6.3.3.7.4 Strategic Initiatives
    • 6.3.3.8 Perrigo Company Plc
    • 6.3.3.8.1 Company Overview
    • 6.3.3.8.2 Financial Performance
    • 6.3.3.8.3 Product Benchmarking
    • 6.3.3.8.4 Strategic Initiatives
    • 6.3.3.9 Amcal
    • 6.3.3.9.1 Company Overview
    • 6.3.3.9.2 Financial Performance
    • 6.3.3.9.3 Product Benchmarking
    • 6.3.3.9.4 Strategic Initiatives
    • 6.3.3.10 GAK Plc
    • 6.3.3.10.1 Company Overview
    • 6.3.3.10.2 Financial Performance
    • 6.3.3.10.3 Product Benchmarking
    • 6.3.3.10.4 Strategic Initiatives

Chapter 7 Conclusion

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Australia nicotine replacement therapy market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
• Table 4 Australia nicotine replacement therapy market revenue estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Australia Nicotine Replacement Therapy Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market and product segment snapshot
• Fig. 10 Distribution channel segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Market dynamics
• Fig. 13 Status of daily smokers - Australia (1991 - 2023)
• Fig. 14 Trend in incidence of lung cancer (2000 - 2023)
• Fig. 15 SWOT analysis, by factor (Political & legal, economic, and technological)
• Fig. 16 Industry analysis - Porter's
• Fig. 17 Australia nicotine replacement therapy market: Product outlook and key takeaways
• Fig. 18 Australia nicotine replacement therapy market: Product movement analysis
• Fig. 19 Nicotine replacement therapy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Inhalers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Gum market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Transdermal patches market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Sublingual tablets market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Lozenges market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 E-cigarettes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Australia nicotine replacement therapy market: Distribution channel outlook and key takeaways
• Fig. 28 Australia nicotine replacement therapy market: Distribution channel movement analysis
• Fig. 29 Online market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Offline market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Others (supermarkets & other modes) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Market participant categorization
• Fig. 35 Australia nicotine replacement therapy market share analysis, 2022